Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
August 03 2023 - 8:00AM
Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company
dedicated to advancing health equity and outcomes through the
delivery of accurate infectious disease testing in the moment of
need, at the point of care, today announced that it will report
second quarter 2023 financial results and provide a business update
on Thursday, August 10, 2023, after market close. Company
management will host a corresponding conference call beginning at
1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
The live webcast of the event may be accessed by registering
online for dial-in information via the News & Events page of
the investor section of Talis Biomedical’s website at
investors.talisbio.com. Participants interested in dialing in to
the conference call are requested to register a day in advance or
at a minimum 15 minutes before the start of the call to obtain a
unique pin for the call.
The webcast will be archived and will be available for replay
via the News & Events page following the call.
About Talis BiomedicalTalis Biomedical is
dedicated to advancing health equity and outcomes through the
delivery of accurate infectious disease testing in the moment of
need, at the point of care. The company plans to develop and
commercialize innovative products on its sample-to-answer Talis
One® system to enable accurate, low cost, and rapid molecular
testing. For more information, visit talisbio.com.
ContactMedia & InvestorsEmily
Faucetteir@talisbio.com415-595-9407
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Jul 2023 to Jul 2024